We found, for instance, that 6 cancer-related targets changed their expression levels: HSPD1 (Ghosh et al., 2008), PARP1 (Cipak and Jantova, 2010), XRCC5 (Yang et al., 2008), PRDX2 (Stresing et al., 2013), MTA2 (Cui et al., 2006) and FASN (Zhou et al., 2003) (Fig. 6C). Here, XRCC5 is linked to cancer.